欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PDF文档下载
    分享到微信 分享到微博 分享到QQ空间

    ASTM F2038-2000(2005) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part I - Formulations and Uncured Materials《医疗设施中用的硅弹性体、凝胶和泡沫的标准指南 第I部分 组成和.pdf

    • 资源ID:536370       资源大小:96.58KB        全文页数:5页
    • 资源格式: PDF        下载积分:5000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要5000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    ASTM F2038-2000(2005) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part I - Formulations and Uncured Materials《医疗设施中用的硅弹性体、凝胶和泡沫的标准指南 第I部分 组成和.pdf

    1、Designation: F 2038 00 (Reapproved 2005)Standard Guide forSilicone Elastomers, Gels, and Foams Used in MedicalApplications Part IFormulations and Uncured Materials1This standard is issued under the fixed designation F 2038; the number immediately following the designation indicates the year oforigin

    2、al adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon (e) indicates an editorial change since the last revision or reapproval.1. Scope1.1 This guide is intended to educate potential users ofsilicone ela

    3、stomers, gels, and foams relative to their formula-tion and use. It does not provide information relative to siliconepowders, fluids, and other silicones. The information providedis offered to guide users in the selection of appropriatematerials, after consideration of the chemical, physical, andtox

    4、icological properties of individual ingredients or by-products. This guide offers general information about siliconematerials typically used for medical applications. Detail on thecrosslinking and fabrication of silicone materials is found inPart II of this guide.1.2 Fabrication and properties of el

    5、astomers is covered inthe companion document, F 604, Part II. This monographaddresses only components of uncured elastomers, gels, andfoams.1.3 Silicone biocompatibility issues can be addressed atseveral levels, but ultimately the device manufacturer mustassess biological suitability relative to int

    6、ended use.1.4 Biological and physical properties tend to be morereproducible when materials are manufactured in accordancewith accepted quality standards such as ANSI ISO 9001 andcurrent FDA Quality System Regulations/Good ManufacturingPractice Regulations.1.5 This standard does not purport to addre

    7、ss all of thesafety concerns, if any, associated with its use. It is theresponsibility of the user of this standard to establish appro-priate safety and health practices and determine the applica-bility of regulatory limitations prior to use. Users are alsoadvised to refer to Material Safety Data Sh

    8、eets provided withuncured silicone components.2. Referenced Documents2.1 ASTM Standards:2D 1566 Terminology Relating to RubberF 813 Practice for Direct Contact Cell Culture Evaluation ofMaterials for Medical Devices2.2 Sterility Standards:3ANSI/AAMI ST41 Good Hospital Practice: Ethylene OxideSterili

    9、zation and Sterility AssuranceANSI/AAMI ST50 Dry Heat (Heated Air) SterilizersANSI/AAMI ST29 Recommended Practice for Determin-ing Ethylene Oxide in Medical DevicesANSI/AAM1 ST30 Determining Residual Ethylene Chlo-rohydrin and Ethylene Glycol in Medical DevicesAAMI 13409-251 Sterilization of Health

    10、Care ProductsRadiation SterilizationSubstantiation of 25kGy as aSterilization Dose for Small or Infrequent ProductionBatchesAAMI TIRS-251 Microbiological Methods for Gamma Ir-radiation Sterilization of Medical Devices2.3 Quality Standards4:ANSI/ASQC Q9001 Quality SystemsModel for QualityAssurance in

    11、 Design, Development Production, Installa-tion, and Servicing21 CFR 820 Quality System Regulation (current revision)21 CFR 210 Current Good Manufacturing Practice inManufacturing, Processing, Packing or Holding of Drugs;General (current revision)21 CFR 211 Current Good Manufacturing Practice forFini

    12、shed Pharmaceuticals (current revision)1This specification is under the jurisdiction of ASTM Committee F04 onMedical and Surgical Materials and Devices and is the direct responsibility ofSubcommittee F04.11 on Polymeric Materials.Current edition approved Mar. 1, 2005. Published March 2005. Originall

    13、ypublished in 2000. Last previous edition approved in 2000 as F 2038 00e1.2For referenced ASTM standards, visit the ASTM website, www.astm.org, orcontact ASTM Customer Service at serviceastm.org. For Annual Book of ASTMStandards volume information, refer to the standards Document Summary page onthe

    14、ASTM website.3Available from American National Standards Institute (ANSI), 25 W. 43rd St.,4th Floor, New York, NY 10036.4Available from U.S. Government Printing Office Superintendent of Documents,732 N. Capitol St., NW, Mail Stop: SDE, Washington, DC 20401.1Copyright ASTM International, 100 Barr Har

    15、bor Drive, PO Box C700, West Conshohocken, PA 19428-2959, United States.3. Terminology3.1 Additional pertinent definitions can be found in Termi-nology D 1566.3.2 Definitions:3.2.1 silicone polymerpolymer chains having a backboneconsisting of repeating silicon-oxygen atoms where eachsilicon atom bea

    16、rs two organic groups. The organic groups aretypically methyl, but can be vinyl, phenyl, fluorine, or otherorganic groups.3.2.2 cyclics and linearslow molecular weight volatilecyclic siloxane species are referred to using the “D” nomen-clature which designates the number of Si-O linkages in themater

    17、ial (usually D4-D20); species from D7to D40(or more)may be called “macrocyclics”. Linears are straight chainoligomers that may be volatile or of higher molecular weight,depending on chain length; they are designated by “M” and“D” combinations, where “M” is R3Si-O, and D is as explainedabove; “R” is

    18、usually methyl. (For example, MDM is (CH3)3SiOSiOSi(CH3)3). Low molecular weight species are presentin silicone components to varying degrees depending onprocess and storage. The levels of macrocyclics that can beremoved from silicone polymers by vacuum, high temperaturestripping, or oven post-cure

    19、is dependent on the conditionsused.3.2.3 catalysta component of a silicone elastomer formu-lation that initiates the crosslinking reaction when the materialis vulcanized.3.2.4 crosslinker or crosslinking agenta component of asilicone elastomer that is a reactant in the crosslinking reactionthat occu

    20、rs when an elastomer is vulcanized.3.2.5 inhibitora component of a silicone elastomer addedto moderate the rate of the crosslinking reaction.3.2.6 fillera finely divided solid that is intimately mixedwith silicone polymers during manufacture to achieve specificproperties. The fillers used in silicon

    21、e elastomers are one oftwo types:3.2.6.1 reinforcing fillersusually have high surface areasand are amorphous in nature such as fumed or precipitatedsilica. Such fillers impart high strength and elastomeric physi-cal properties to the elastomer.3.2.6.2 extending fillerstypically have lower surface ar

    22、eaand lower cost than reinforcing fillers. They include crystallineforms of silica and diatomaceous earths. While they providesome reinforcement, because they are relatively inexpensive,they are used primarily to extend the bulk of the silicone.3.2.7 additivesa component of a silicone elastomer used

    23、in relatively small amounts to perform functions such asmarking, coloring, or providing opacity to the elastomer.3.2.8 silicone basea uniformly blended mixture of sili-cone polymers, fillers, and additives which does not containcrosslinkers or catalyst.3.2.9 uncured elastomera silicone base which co

    24、ntainscrosslinker and/or catalyst but has not been vulcanized.3.2.10 silicone elastomeran uncured elastomer that hasbeen subjected to conditions which cause it to becomecrosslinked. Elastomers may be either high consistency rub-bers, low consistency rubbers, or RTVs (see below).3.2.10.1 high consist

    25、ency rubbers (HCRS)are materialswhich cannot be pumped by conventional pumping equipment.They normally must be processed using high shear equipmentsuch as a two-roll mill and parts are typically fabricated usingcompression or transfer molding techniques.3.2.10.2 low consistency rubbers or liquid sil

    26、icone rubbers(LSRS)are normally flowable materials which can be readilypumped. They can be mixed by pumping through static mixersand parts can be fabricated using injection molding techniques.3.2.10.3 RTVs (room temperature vulcanization) are one-part elastomers which cure in the presence of atmosph

    27、ericmoisture. Little, if any, acceleration of cure rate is realized byincreasing temperature. Because cure is dependent upon diffu-sion of water into the elastomer, cure in depths greater than0.25 in. (0.635 cm) is not recommended.3.2.10.4 gelsare lightly crosslinked materials having noor relatively

    28、 low levels of reinforcement beyond that providedby the crosslinked polymer. They are usually two-part formu-lations utilizing a platinum catalyzed addition cure system. Thehardness of the gel can be adjusted within wide limits. Thematerial is not usually designed to bear heavy loads but ratherto co

    29、nform to an irregular surface providing intimate contact.As a result, loads are distributed over a wider area. Thesematerials may also be used to provide protection from envi-ronmental contaminants.3.2.10.5 foamsare crosslinked materials which have acomponent added to them that generates a volatile

    30、gas as thematerial is being vulcanized. This results in a material with avery low density. These are usually two-part formulationsutilizing a platinum catalyzed addition cure system. Theyconform to an irregular surface as they expand to provideintimate contact and protection from the environment but

    31、 aremore rigid and provide more strength than gels. Since foamsare expanded elastomers, on a weight basis they are highlycrosslinked relative to gels. Most cure conditions will result ina closed cell foam.3.2.11 lot or batcha quantity of material made with afixed, specified formulation in a single,

    32、manufacturing runcarried out under specific processing techniques and condi-tions.3.2.12 vulcanizationan irreversible process in which co-valent chemical bonds are formed between silicone polymerchains. During vulcanization, the material changes from aflowable or moldable compound to an elastomeric

    33、materialwhich cannot be reshaped except by its physical destruction.3.2.13 types of curebased upon the cure chemistry em-ployed, silicone elastomers used in medical applications fallinto one of three categories: condensation cure, peroxide cure,and addition cure.3.2.13.1 condensation curethese mater

    34、ials liberate an or-ganic leaving group during curing and are normally catalyzedby an organometallic compound.one-partmaterial supplied ready to use in an air tightcontainer which cures upon exposure to atmospheric moisture.The material cures from the surface down and cure depths ofgreater than abou

    35、t 0.25 inches (0.635 cm) are not practical.two-partmaterial supplied in two separate containerswhich must be intimately mixed in the prescribed proportionsF 2038 00 (2005)2shortly before use. Because they do not rely upon dispersion ofatmospheric moisture into the silicone, the cure depth is notlimi

    36、ted.3.2.13.2 peroxide cureone-part formulations vulcanizedby free radicals generated by the decomposition of an organicperoxide.3.2.13.3 addition curetwo-part elastomers which mustfirst be mixed together and then cure by addition of asilylhydride to a vinyl silane in the presence of a platinumcataly

    37、st.3.2.14 dispersionan uncured silicone elastomer dispersedin a suitable solvent to allow application of a thin layer ofelastomer to a substrate by either dipping or spraying.4. Significance and Use4.1 This guide is intended to provide guidance for thespecification and selection of silicone material

    38、s for medicaldevice applications.4.2 Silicone manufacturers supplying materials to the medi-cal device industry should readily provide information regard-ing non-proprietary product formulation to their customerseither directly, or through the US FDA master file program.5. Formulation5.1 Elastomers,

    39、 gels, and foams shall be manufactured usingformulations containing combinations of the following rawmaterials.5.1.1 silicone polymerany polymer of medium or highmolecular weight of the structure shown in Fig. 1 where R is amethyl, an unsaturated alkyl group or a hydroxy group, R isgenerally a methy

    40、l or an unsaturated alkyl group but may alsobe a phenyl, trifuoropropyl, or other hydrocarbon radical, andx and y are integers greater than or equal to zero. At least 2.0alkenyl groups must exist per chain if R is not a hydroxy group.5.1.2 catalystan organometallic complex of platinum ortin bonded t

    41、o ligands made of any suitable combination ofelements such as carbon, hydrogen, oxygen, fluorine andsilicon.5.1.2.1 platinumthis catalyst may be dispersed in a sili-cone polymer of the structure shown in Fig. 1 having aviscosity low enough that the resulting dispersion is easilypourable. Platinum ca

    42、talysts can be used in the range of 5 to 20ppm of active platinum but typically are present at about 7.5ppm.5.1.2.2 tinone-part condensation cure formulations willtypically contain from 0.1 to 0.5 wt percent of an organotincompound. Two-part condensation cure formulations will typi-cally contain fro

    43、m 0.5 to 2.0 weight percent organotin com-pound. The ligands attached to tin will be some combination ofalkyl groups, alkoxy groups, or the anions of a carboxylic acid.5.1.3 Crosslinker or crosslinking agent:5.1.3.1 Two-part, addition cure formulationthecrosslinker is a polymer of the structure show

    44、n in Fig. 2 whereR is generally a methyl or a hydrogen group such as to provideat least 2.0 SiH groups per chain and x and y are integersgreater than or equal to zero. In order to avoid chain extension,the functionality of either the vinyl-containing polymer or theSiH-containing crosslinker must be

    45、at least 3.0.Because of the limitless possibilities for the structure of boththe crosslinker and the functional (vinyl containing) polymer, itwould be meaningless to define a weight range for the level ofcrosslinker in a formulation. However, the amount ofcrosslinker will typically be sufficient to

    46、provide a stoichio-metric excess of SiH groups over the amount of unsaturatedalkyl groups when the 2 components (parts) of the additioncure silicone elastomer are mixed together in the manufactur-ers recommended ratio.5.1.3.2 One-part RTVs and two-part addition cureformulationsthe crosslinker may be

    47、 an organosilane mono-mer of the general formula:RxSiOR!42x(1)where:R = organic group excluding phenylOR = hydrolyzable group such as alkoxy, acetoxy, ke-toximo, etc.5.1.3.3 Peroxide vulcanized elastomersorganic peroxidescomprise a third type of crosslinking agent which participatesin the crosslinki

    48、ng reaction that does not become directlyincorporated into the crosslinked network. Peroxide levelsrange from less than a percent to as high as a couple of weightpercent in the total formulation. These peroxides decompose, ata rate which is dependent upon the temperature, to formradicals which then

    49、abstract hydrogen atoms from some of thealkyl groups attached to the silicone backbone. Recombinationof these radicals results in the formation of a crosslinkedsilicone network. One commonly used peroxide is 2,4,-dichlorobenzoyl peroxide. Decomposition of this peroxideresults in the formation of small amounts of polychlorinatedbiphenyls and other catalyst decomposition by-products whichmust be, and are, removed from the cured elastomer duringpost-curing.5.1.4 Fillera high purity amorphous silica commerciallyknown as fumed or precipitated sili


    注意事项

    本文(ASTM F2038-2000(2005) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part I - Formulations and Uncured Materials《医疗设施中用的硅弹性体、凝胶和泡沫的标准指南 第I部分 组成和.pdf)为本站会员(explodesoak291)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开